University spin out company addresses new vaccines

August 8, 2017, University of Plymouth
Dr. Michael Jarvis, Chief Scientific Officer of The Vaccine Group. Credit: University of Plymouth

The University of Plymouth has launched a new spin out company which will address new vaccines for diseases which spread from animals to humans and for use in infection control.

Governments, pharmaceutical companies and supranational bodies are showing increasing concern about emerging infectious diseases. The Vaccine Group will exploit technology developed by Dr Michael Jarvis, Associate Professor in Virology and Immunology at the University of Plymouth, who specialises in the creative design of herpesvirus-based vaccines for the control of disease.

The Vaccine Group aims to commercialise new platforms for the development of vaccines for use in (such as bovine tuberculosis) and for a rapid response to pathogens which unpredictably cross the species barrier and pose a significant threat to . Target pathogens include avian influenza A, Ebola and Marburg viruses, MERS and SARS coronaviruses and Rift Valley fever virus.

Dr Jarvis' work has previously received funding from a number of sources, including UK Innovate, National Institutes of Health and the Medical Research Council. Initial work in The Vaccine Group will focus on herpesvirus-based platforms suitable for use in animals, to protect human health by targeting the animal species from which is transmitted to humans, for vaccination (termed zoonoses barrier vaccines). Future developments will include vaccines for use in humans.

Dr Michael Jarvis, Chief Scientific Officer of The Vaccine Group, said: "My laboratory has nearly 20 years' experience in the development of vaccines based on herpesvirus-based technology. Science is a collaborative endeavour, and The Vaccine Group provides a new vehicle by which we can interact with fellow scientists, industry and investors to prevent emergence of relevant to global human health and agriculture."

The Vaccine Group is supported by the University of Plymouth and the Frontier IP Group plc, which specialises in assisting institutions and companies in the commercialisation and exploitation of their intellectual property.

Explore further: New study highlights effectiveness of a herpesvirus CMV-based vaccine against Ebola

Related Stories

New study highlights effectiveness of a herpesvirus CMV-based vaccine against Ebola

February 15, 2016
As the latest in a series of studies, researchers at Plymouth University, National Institutes of Health and University of California, Riverside, have shown the ability of a vaccine vector based on a common herpesvirus called ...

Could self-disseminating vaccines cut off emerging infectious diseases at source?

November 2, 2015
The 2014/2015 Ebola outbreak in West Africa shone the spotlight not only on the unpreparedness of local health services and science to deal with the pandemic, but also on the phenomenon of emerging infectious diseases (EIDs).

Researchers take an important step toward an HIV vaccine

May 17, 2017
Researchers from the University of Copenhagen have developed a strategy that can revolutionize vaccine design. The new strategy is used to develop vaccines that can prevent HIV infection and the development of AIDS.

New experimental vaccine produces immune response against MERS virus

April 30, 2014
The University of Maryland School of Medicine (UM SOM) and Novavax, Inc. today announced that an investigational vaccine candidate developed by Novavax against the recently emerged Middle East Respiratory Syndrome Coronavirus ...

Recommended for you

Scientists a step closer to predicting epidemics

July 13, 2018
Ecologists at the University of Georgia have taken an important step in their efforts to develop an early warning system for infectious disease outbreaks.

Researchers identify target for novel malaria vaccine

July 13, 2018
A Yale-led team of researchers have created a vaccine that protects against malaria infection in mouse models, paving the way for the development of a human vaccine that works by targeting the specific protein that parasites ...

Higher income and being married protect older people from broken bones

July 13, 2018
Research led by scientists from the Medical Research Council Lifecourse Epidemiology Unit (MRC LEU) at the University of Southampton has shown that a higher income and being married reduces the risk of experiencing a broken ...

Gammaherpesviruses linked to tumors in macaques with simian immunodeficiency virus

July 12, 2018
Viruses known as gammaherpesviruses may raise the risk of cancer in macaques infected with Simian Immunodeficiency Virus or Simian Human Immunodeficiency Virus (SIV/SHIV), according to new research published by Vickie Marshall ...

Scientists find protein exploited by virus ravaging West Africa

July 12, 2018
A research team from several institutions being led by the University of California San Diego has deciphered a key component behind a rising epidemic of pathogens that the World Health Organization (WHO) recently added to ...

How a Mediterranean diet could reduce osteoporosis

July 11, 2018
Eating a Mediterranean-type diet could reduce bone loss in people with osteoporosis—according to new research from the University of East Anglia.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.